Self-reduction of the iron(III)-doxorubicin complex
- 15 January 1989
- journal article
- research article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 7 (6) , 583-593
- https://doi.org/10.1016/0891-5849(89)90139-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Adriamycin (doxorubicin)-induced inactivation of cytochrome c oxidase depends on the presence of iron or copperXenobiotica, 1989
- Adriamycin and its iron(III) and copper(II) complexesBiochemical Pharmacology, 1988
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988
- The iron(III)-adriamycin complex inhibits cytochrome c oxidase before its inactivationBiochemical Journal, 1988
- Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycinBiochemical Pharmacology, 1985
- Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron (III) complexBiochemical Pharmacology, 1984
- NADH oxidation in submitochondrial particles protects respiratory chain activity against damage by adriamycin‐Fe3+European Journal of Biochemistry, 1983
- Destruction of Phosphilipids and Respiratory‐Chain Activity in Pig=Heart Submitochondrial Particles Induced by an Adriamycin‐Iron ComplexEuropean Journal of Biochemistry, 1983
- Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complexBiochemistry, 1982
- Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycinBiochemical and Biophysical Research Communications, 1977